The Role of Obesity in Type 2 Diabetes Mellitus-An Overview

被引:56
|
作者
Chandrasekaran, Preethi [1 ]
Weiskirchen, Ralf [2 ]
机构
[1] UT Southwestern Med Ctr Dallas, 5323 Harry Hines Blvd ND10 504, Dallas, TX 75390 USA
[2] Univ Hosp Aachen, Rheinisch Westfalische TH RWTH, Inst Mol Pathobiochem Expt Gene Therapy & Clin Che, D-52074 Aachen, Germany
关键词
obesity; type; 2; diabetes; pathophysiology; incidence; prevalence; management; therapeutic approach; in vivo studies; clinical trials; IMPROVES INSULIN-RESISTANCE; ADIPOSE-TISSUE; OXIDATIVE STRESS; METABOLIC SYNDROME; WEIGHT MANAGEMENT; PEPTIDE-1; ANALOG; FAT ACCUMULATION; MOUSE MODEL; WHITE; OVERWEIGHT;
D O I
10.3390/ijms25031882
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Obesity or excessive weight gain is identified as the most important and significant risk factor in the development and progression of type 2 diabetes mellitus (DM) in all age groups. It has reached pandemic dimensions, making the treatment of obesity crucial in the prevention and management of type 2 DM worldwide. Multiple clinical studies have demonstrated that moderate and sustained weight loss can improve blood glucose levels, insulin action and reduce the need for diabetic medications. A combined approach of diet, exercise and lifestyle modifications can successfully reduce obesity and subsequently ameliorate the ill effects and deadly complications of DM. This approach also helps largely in the prevention, control and remission of DM. Obesity and DM are chronic diseases that are increasing globally, requiring new approaches to manage and prevent diabetes in obese individuals. Therefore, it is essential to understand the mechanistic link between the two and design a comprehensive approach to increase life expectancy and improve the quality of life in patients with type 2 DM and obesity. This literature review provides explicit information on the clinical definitions of obesity and type 2 DM, the incidence and prevalence of type 2 DM in obese individuals, the indispensable role of obesity in the pathophysiology of type 2 DM and their mechanistic link. It also discusses clinical studies and outlines the recent management approaches for the treatment of these associated conditions. Additionally, in vivo studies on obesity and type 2 DM are discussed here as they pave the way for more rigorous development of therapeutic approaches.
引用
收藏
页数:21
相关论文
共 50 条
  • [1] Type 2 diabetes mellitus-an autoimmune disease?
    Velloso, Licio A.
    Eizirik, Decio L.
    Cnop, Miriam
    NATURE REVIEWS ENDOCRINOLOGY, 2013, 9 (12) : 750 - 755
  • [2] Atorvastatin prevents type 2 diabetes mellitus-An experimental study
    Madhu, Venkata
    Aslam, Mohammad
    Galav, Vikas
    Bhattacharya, Swapan Kumar
    Jafri, Aiman Abbas
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 728 : 135 - 140
  • [3] Obesity and Type 2 diabetes mellitus
    Wilding, J
    DIABETIC MEDICINE, 2000, 17 (05) : 400 - 402
  • [4] Obesity and Type 2 Diabetes Mellitus
    Sharma, Arya M.
    Lau, David C. W.
    CANADIAN JOURNAL OF DIABETES, 2013, 37 (02) : 63 - 64
  • [5] Obesity and type 2 diabetes mellitus
    Noakes, Manny
    Keogh, Jennifer
    Clifton, Peter
    NUTRITION & DIETETICS, 2007, 64 : S156 - S161
  • [6] β-Carotene: Preventive Role for Type 2 Diabetes Mellitus and Obesity: A Review
    Marcelino, Gabriela
    Machate, David Johane
    Freitas, Karine de Cassia
    Hiane, Priscila Aiko
    Maldonade, Iriani Rodrigues
    Pott, Arnildo
    Asato, Marcel Arakaki
    Candido, Camila Jordao
    Avellaneda Guimaraes, Rita de Cassia
    MOLECULES, 2020, 25 (24):
  • [7] Prevalence and role of obesity and hypertension in type 2 diabetes mellitus patients
    Disoteo, O.
    Pizzi, G.
    Fossati, C.
    JOURNAL OF HYPERTENSION, 2007, 25 : S192 - S192
  • [8] The pathophysiology of type 2 diabetes mellitus:: an overview
    Östenson, CG
    ACTA PHYSIOLOGICA SCANDINAVICA, 2001, 171 (03): : 241 - 247
  • [9] Type 2 diabetes mellitus: The grand overview
    Ratner, RE
    DIABETIC MEDICINE, 1998, 15 (12) : S4 - S7
  • [10] The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity
    Ningwen Tai
    F. Susan Wong
    Li Wen
    Reviews in Endocrine and Metabolic Disorders, 2015, 16 : 55 - 65